These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 18760635)
1. Retention of new AEDs in institutionalized intellectually disabled patients with epilepsy. Carpay JA; Aalbers K; Graveland GA; Engelsman M Seizure; 2009 Mar; 18(2):119-23. PubMed ID: 18760635 [TBL] [Abstract][Full Text] [Related]
2. Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study. Peltola J; Peltola M; Auvinen A; Raitanen J; Fallah M; Keränen T Acta Neurol Scand; 2009 Jan; 119(1):55-60. PubMed ID: 18616622 [TBL] [Abstract][Full Text] [Related]
3. New pharmacotherapies for pediatric seizures. Pellock JM Pediatr Ann; 2004 Jun; 33(6):385-91. PubMed ID: 19449513 [No Abstract] [Full Text] [Related]
4. Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy. Arif H; Buchsbaum R; Pierro J; Whalen M; Sims J; Resor SR; Bazil CW; Hirsch LJ Arch Neurol; 2010 Apr; 67(4):408-15. PubMed ID: 20385905 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; Neurology; 2004 Apr; 62(8):1261-73. PubMed ID: 15111660 [TBL] [Abstract][Full Text] [Related]
7. An audit of lamotrigine, levetiracetam and topiramate usage for epilepsy in a district general hospital. Chappell B; Crawford P Seizure; 2005 Sep; 14(6):422-8. PubMed ID: 16087359 [TBL] [Abstract][Full Text] [Related]
8. New antiepileptic drugs in pediatric epilepsy. Hwang H; Kim KJ Brain Dev; 2008 Oct; 30(9):549-55. PubMed ID: 18328657 [TBL] [Abstract][Full Text] [Related]
9. New antiepileptic drugs in practice--how do they perform in the real world? Sander JW Acta Neurol Scand Suppl; 2005; 181():26-9. PubMed ID: 16238705 [TBL] [Abstract][Full Text] [Related]
10. The impact of side effects on long-term retention in three new antiepileptic drugs. Bootsma HP; Ricker L; Hekster YA; Hulsman J; Lambrechts D; Majoie M; Schellekens A; de Krom M; Aldenkamp AP Seizure; 2009 Jun; 18(5):327-31. PubMed ID: 19110447 [TBL] [Abstract][Full Text] [Related]
11. Comparative persistence of antiepileptic drugs in patients with epilepsy: A STROBE-compliant retrospective cohort study. Lai EC; Hsieh CY; Su CC; Yang YK; Huang CW; Lin SJ; Setoguchi S Medicine (Baltimore); 2016 Aug; 95(35):e4481. PubMed ID: 27583857 [TBL] [Abstract][Full Text] [Related]
12. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy. Lhatoo SD; Wong IC; Polizzi G; Sander JW Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; Neurology; 2004 Apr; 62(8):1252-60. PubMed ID: 15111659 [TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population. Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266 [TBL] [Abstract][Full Text] [Related]
15. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison. Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131 [TBL] [Abstract][Full Text] [Related]
16. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood. McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564 [TBL] [Abstract][Full Text] [Related]
17. Use of new antiepileptic drugs in the treatment of childhood epilepsy. Pellock JM; Appleton R Epilepsia; 1999; 40 Suppl 6():S29-38; discussion S73-4. PubMed ID: 10530681 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of health status in epilepsy using the EQ-5D questionnaire: a prospective, observational, 6-month study of adjunctive therapy with anti-epileptic drugs. Selai CE; Trimble MR; Price MJ; Remak E Curr Med Res Opin; 2005 May; 21(5):733-9. PubMed ID: 15969872 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ; Epilepsia; 2004 May; 45(5):401-9. PubMed ID: 15101821 [TBL] [Abstract][Full Text] [Related]
20. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. Otoul C; De Smedt H; Stockis A Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]